Kezar Life Sciences, Inc. — Director's Dealing 2018

Jun 20, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-20

Reporting Person: COOPER GRAHAM K (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.37	2027-10-09	Common Stock (37427)		Direct
Stock Option (Right to Buy)	$5.91	2028-04-15	Common Stock (8896)		Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on October 10, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the last day of the month, subject to Reporting Person continuing to provide service through each such date.

F2: One-hundred percent (100%) of the shares subject to the option shall vest on January 1, 2019, subject to Reporting Person continuing to provide service through such date.